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Abstract
Background: Drosophila dorso-ventral (DV) patterning is one of the best-understood regulatory networks to date,
and illustrates the fundamental role of enhancers in controlling patterning, cell fate specification, and morphogenesis
during development. Histone acetylation such as H3K27ac is an excellent marker for active enhancers, but it is
challenging to obtain precise locations for enhancers as the highest levels of this modification flank the enhancer
regions. How to best identify tissue-specific enhancers in a developmental system de novo with a minimal set of data
is still unclear.
Results: Using DV patterning as a test system, we develop a simple and effective method to identify tissue-specific
enhancers de novo. We sample a broad set of candidate enhancer regions using data on CREB-binding protein
co-factor binding or ATAC-seq chromatin accessibility, and then identify those regions with significant differences in
histone acetylation between tissues. This method identifies hundreds of novel DV enhancers and outperforms ChIP-seq
data of relevant transcription factors when benchmarked with mRNA expression data and transgenic reporter assays.
These DV enhancers allow the de novo discovery of the relevant transcription factor motifs involved in DV patterning
and contain additional motifs that are evolutionarily conserved and for which the corresponding transcription factors
are expressed in a DV-biased fashion. Finally, we identify novel target genes of the regulatory network, implicating
morphogenesis genes as early targets of DV patterning.
Conclusions: Taken together, our approach has expanded our knowledge of the DV patterning network even further
and is a general method to identify enhancers in any developmental system, including mammalian development.
Keywords: Enhancer identification, CBP, ATAC-seq, H3K27ac
Background
Identifying and deciphering the function of cis-regula-
tory enhancers in the genome is a major challenge but
has become an attainable goal over the past decade
thanks to genomics approaches. An intrinsic difficulty is
that enhancer function during development is highly
stage- and tissue-specific, which makes it challenging to
obtain sufficient material from developing embryos for
analysis. Model organisms such as Drosophila, for which
development is well-studied and large amounts of cells
can be obtained, are therefore an excellent system to test
our ability to identify enhancers involved in embryonic
development. Dorso-ventral (DV) pattern formation in
the early Drosophila embryo is a good example. DV pat-
terning is one of the earliest patterning processes in the
metazoan embryo [1], relevant to understanding early
pattern formation and morphogenetic movements, in-
cluding gastrulation. As a result of systematic genetic
screens in the 1980s, molecular analysis in the 1990s,
and genomic approaches in the 2000s, it is one of the
best-understood developmental networks to date. Im-
portantly, the DV patterning system is experimentally
accessible due to well-characterized mutants.
In Drosophila, DV patterning sets up the initial germ
layers: mesoderm on the most ventral side, neurectoderm
in the middle, and dorsal ectoderm on the dorsal side,
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which also gives rise to the extraembryonic amnioserosa
most dorsally. Patterning these tissues requires the graded
activity of two conserved signal transduction pathways,
the Toll (Tl) and bone morphogenetic protein (BMP) sig-
naling pathways.
Maternally deposited signals activate the Tl signaling
pathway on the ventral side and lead to high nuclear
concentrations of the NF-kB transcription factor Dorsal
(Dl) [2]. High levels of nuclear Dl then induce the
expression of two additional transcription factors, Twist
(Twi) and Snail (Sna) [3–5], which together specify
mesodermal fate on the ventral side. Dl also represses
decapentaplegic (dpp), which encodes the main Drosoph-
ila BMP homolog [6], and zerknüllt (zen), which encodes a
homeodomain transcription factor [7, 8]. Due to ventral re-
pression, dpp and zen are expressed on the dorsal side and
specify the amnioserosa and the dorsal ectoderm [9–11].
Dpp activity on the dorsal side activates the transcription
factor Mothers against dpp (Mad) [12].
Over the years, many enhancers have been characterized
that are differentially activated along the DV axis, and
their identification reflects the progress in technology.
Initially, enhancers were identified by testing DNA near
the promoters of known DV target genes for regulatory
activity in lacZ reporter assays [3, 4, 6, 8] or by testing
DNA regions located near a lacZ enhancer trap reporter
with DV expression [13]. Additional DV enhancers
were identified by bioinformatics searches for regions
with multiple transcription factor binding motif occur-
rences [14, 15].
The advent of genomics approaches greatly accelerated
the identification of putative DV enhancers, in part due to
the availability of mutant lines where all embryos in the
progeny consist of either mesodermal, neurectodermal, or
dorsal ectodermal precursor cells (Tl10b, Tlrm9/rm10, and
gd7), yielding sufficient amounts of cells for genomics as-
says. Early expression-based methods identified novel DV
target genes and enhancers by analyzing differences in
mRNA levels between these DV mutants [16, 17]. Subse-
quent ChIP-chip and later ChIP-seq experiments enabled
the systematic identification of regions that are bound by
DV transcription factors in vivo, and many of these re-
gions were confirmed as DV enhancers by lacZ reporter
assays [18–20].
Despite the general success of transcription factor
ChIP-seq experiments in identifying enhancers, there are
some caveats to the approach. First, transcription factor
occupancy can only be obtained if the relevant transcrip-
tion factors are known and specific antibodies are avail-
able. In less well-studied systems or model organisms,
this can be a significant experimental obstacle. Second,
transcription factors occupy a large number of putative
enhancers and have an uncertain number of false posi-
tives. For example, the Twi and Sna ChIP signal can be
detected at thousands of putative regulatory regions
[18–21], but genetics and gene expression data predict a
much smaller number of target genes [16]. While bona
fide enhancers tend to have a high ChIP signal [19, 22],
not all Twi regions that were selected based on high
ChIP signal were confirmed in transgenic reporter assays
[19, 20].
An emerging realization is that the binding of transcrip-
tion factors, as well as those of co-activators, occurs to
some degree promiscuously at regions of open chromatin
and may not necessarily indicate regulatory activity
[22–25]. This conclusion is consistent with imaging stud-
ies, suggesting frequent non-specific collisions of transcrip-
tion factors with DNA [26, 27] and thus questions the
reliability of transcription factor occupancy for enhancer
identification. However, in the absence of a gold standard, it
is difficult to systematically evaluate the strengths and
weaknesses of various methods.
As an alternative to transcription factor occupancy,
acetylation of lysine 27 on histone H3 (H3K27ac) has
been shown to be a reliable marker for active enhancers
in mammalian systems [28–30] and in Drosophila [31].
However, methods by which H3K27ac could be system-
atically used to identify enhancers in a developmental
context have not yet been explored in detail. Such ana-
lysis is not straightforward, because H3K27ac is found
in broad regions flanking active enhancers and is not
found at active enhancers themselves, which are de-
pleted of nucleosomes [28, 31]. How to best identify
putative regions that might represent active enhancers and
how to use H3K27ac ChIP-seq data as a measurement for
tissue-specific activity in the embryo is therefore not en-
tirely clear.
Here we used the well-studied DV patterning system
to determine how to best use H3K27ac data to identify
tissue-specific enhancers. We find that a highly effective
method is to first use an independent dataset to identify
candidate enhancer regions and then to specifically
query these regions for differential H3K27ac across
tissues. We show that candidate enhancer regions can
be identified with ChIP-seq data of the co-activator
CREB-binding protein (CBP or Nejire in Drosophila)
or the assay for transposase-accessible chromatin using se-
quencing (ATAC-seq) [32].
Using this approach, we identified several hundred pu-
tative enhancers for mesoderm and dorsal ectoderm that
we validated with expression data, transgenic reporter
assays, and transcription factor motif analyses. Notably,
the regions identified by differential H3K27ac analysis
were more accurate in their expected motif content and
tissue specificity compared to regions identified by tran-
scription factor occupancy (ChIP-chip or ChIP-seq).
With these newly identified DV enhancers, we were
able to identify de novo the motifs of most known DV
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transcription factors and show that these motifs are
highly conserved across species. Furthermore, we iden-
tify novel DV target genes, including transcription fac-
tors and signaling components, as well as genes involved
in morphogenesis that may function in early tissue
movements, including gastrulation. Since our approach
is a general method to identify enhancers that are differ-
entially active between tissues, it should be applicable to
any developmental system, including vertebrate tissues.
Results
Known DV enhancers are marked by relative differences
in H3K27ac across tissues
To identify novel DV enhancers using H3K27ac, we fo-
cused on the most ventral and the most dorsal tissue by
using Tl10b embryos and gd7 embryos. Tl10b embryos have
uniformly high Dl activity throughout the embryo and thus
represent the presumptive mesoderm on the ventral side
[33]. gd7 embryos completely lack Dl activation and repre-
sent the presumptive dorsal ectoderm on the dorsal side
[34]. We then performed replicate ChIP-seq experiments
for H3K27ac and mRNA-seq in each DV mutant during
the time in which DV patterning takes place (2–4 h after
egg deposition (AED), corresponding to embryonic stages
5–9). Replicate experiments were highly reproducible
(Additional file 1: Supplementary material).
To explore how H3K27ac could be used to identify
novel DV enhancers, we first analyzed the pattern of
H3K27ac at known DV enhancers. We defined known DV
enhancers as those for which DV-specific reporter
gene expression has been reported in the literature
(see Additional file 2: Table S1 and Additional file 1:
Supplementary material). Since the known enhancers
vary in size dependent on how they were discovered,
we measured H3K27ac ChIP-seq enrichment for each
enhancer within a fixed 1-kb window centered on the
enhancer’s midpoint. This window is large enough to
extend beyond the nucleosome-depleted enhancer re-
gion, thus sampling the flanking H3K27ac levels, but
is small enough to avoid sampling potential H3K27ac
enrichment from other enhancers nearby. Thus, the 1-kb
window is sufficient to detect changes in H3K27ac while
maximizing resolution, i.e., to distinguish between the ac-
tivity of two neighboring enhancers.
We first tested whether the H3K27ac enrichment
levels at each enhancer could be used as an absolute
marker for enhancer activity in each tissue. By using the
transcript levels of the corresponding target genes as a
proxy for each enhancer’s activity, we found a reasonably
high correlation between H3K27ac enrichment and en-
hancer activity in both tissues (R2 = 0.36 and R2 = 0.51,
Fig. 1a, see Additional file 3: Figure S1 for gene names).
This general trend is consistent with previous reports
[28–30].
Although H3K27ac was overall a good marker for ac-
tive enhancers, H3K27ac enrichment values are found in
a continuum, and high H3K27ac enrichment in one tis-
sue was not a good marker for its tissue-specific activity
(Fig. 1a). For example, active enhancers tend to have
higher H3K27ac enrichments; however, within the same
tissue, H3K27 enrichments are not always higher at ac-
tive compared to inactive enhancers (the yellow and blue
dots are not separated in Fig. 1a).
We therefore tested whether the relative difference be-
tween H3K27ac at each enhancer across tissues would
be a better measurement for the tissue specificity. Indeed,
when we plotted the relative difference in transcript levels
against the relative difference in H3K27ac levels for all en-
hancers, the tissue specificity of each enhancer became ap-
parent. The majority of enhancers showed both higher
H3K27ac and higher transcript levels in the expected tis-
sue (the blue and yellow dots are much more separated
from each other in Fig. 1b). Strikingly, this also improved
the overall correlation (R2 = 0.76, Fig. 1b). This suggests
that analyzing the absolute levels of histone modifications
is useful, but that in a typical biological setting, a more ef-
fective way of identifying tissue-specific enhancers is to
focus on relative differences in H3K27ac between tissues.
We therefore used relative H3K27ac differences between
tissues to identify putative DV enhancers. When applied
across the genome, differential H3K27ac analysis also has
the advantage of identifying only tissue-specific enhancers,
while excluding enhancers that are equally active in both
tissues.
Identification of candidate enhancer regions through CBP
ChIP-seq or ATAC-seq
So far we used the location of known DV enhancers to
measure relative differences in H3K27ac levels. To identify
DV enhancers throughout the genome de novo, we could
systematically analyze any differences in H3K27ac between
tissues. However, since the peak levels of H3K27ac are
found next to enhancers, this approach would not identify
the exact location of putative DV enhancers. We therefore
decided to systematically map the location of putative en-
hancer regions first and to specifically test these regions
for significant differences in H3K27ac levels within a 1-kb
window (Fig. 1c).
To identify candidate regions, we did not use transcrip-
tion factor ChIP-seq data, since they could introduce a
bias towards a specific set of target genes and potentially a
specific tissue, which we wished to avoid. Furthermore, we
wanted to develop a method that would be generally ap-
plicable to any developmental system, without knowledge
of the transcription factors involved.
A commonly used marker for enhancers is the co-factor
CBP [28, 35, 36]. Although its binding is not restricted to
enhancers [37], CBP is the main histone acetyl transferase
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that catalyzes H3K27ac in Drosophila [38]. Therefore,
regions with CBP binding should serve as excellent
candidates for querying differential H3K27ac across the
genome. To test this approach, we performed CBP ChIP-
seq experiments on Drosophila embryos (2–4 h AED) and
identified 15,477 candidate enhancer regions.
Another approach is to use regions of open chromatin
as candidate enhancer regions. Chromatin accessibility is
thought to be a general feature of enhancers and can be
measured in any developmental system without the
need for specific antibodies. A recently developed assay,
ATAC-seq, can be used for this purpose with a relatively
small number of cells and thus should be particularly
attractive for developmental systems. We therefore per-
formed ATAC-seq on Drosophila embryos (2–4 h AED)
and identified 29,510 accessible regions.
We next tested the suitability of the CBP and ATAC
regions as candidate enhancers and found that CBP re-
gions overall performed slightly better. First, CBP regions
covered more known DV enhancers (57 out of 59) than
did ATAC regions (51 out of 59). Second, when we com-
pared these regions to Vienna Tiles (VTs) that have been
documented to drive transgenic reporter gene expression
[39], we found that tiles overlapping the top 10,000 CBP
regions were more frequently annotated with early embryo
expression patterns than tiles overlapping the top 10,000
ATAC regions (52 % among CBP regions versus 33 %
among ATAC regions), suggesting that a greater portion
of CBP regions than ATAC regions are functional en-
hancers. Finally, we found less evidence for sequence bias
among the CBP regions. Among the top 500 CBP regions,
the motif of Zelda (Zld) was enriched (Additional file 3:
Figure S2). This is expected, since it is the most common
motif among all early enhancers [40]. Although CBP has
been reported to interact with a number of transcription
factors (see, e.g., [41, 42], no motifs involved in embryonic
patterning were enriched among the top 500 CBP regions
(Additional file 3: Figure S2), arguing against a bias
towards certain signaling pathways. ATAC regions did
not show any bias towards patterning transcription factors
either, but a number of repetitive motifs showed signifi-
cant enrichment, which could indicate a certain sequence
bias in this group (Additional file 3: Figure S2).
Taken together, our analysis suggests that CBP regions
are more likely to be enhancers and are less sequence-
biased compared to ATAC-seq regions. We therefore
present the results from using CBP regions as the starting
point for our analysis. However, we have also performed
the same analysis for ATAC-seq regions and found similar
results (shown in Additional file 3: Figures S2–S5), sug-
gesting that ATAC-seq regions are a useful alternative to
CBP regions.
Large-scale differential H3K27ac analysis on candidate
regions reveals hundreds of putative DV enhancers
To systematically query our CBP candidate enhancer
regions for significantly different H3K27ac levels between
tissues, we applied the Bioconductor package DESeq2
[43]. Strikingly, hundreds of regions are significantly
different between the two tissues (q value <0.01 after
Benjamini-Hochberg correction). We obtained 594 regions
with higher H3K27ac in Tl10b versus gd7, thus putative
mesoderm enhancers (MEs) (blue dots in Fig. 1c), and 572
regions with higher H3K27ac in gd7 versus Tl10b, thus puta-
tive dorsal ectoderm enhancers (DEEs) (yellow dots in
Fig. 1c). Among these regions were 34 known DV en-
hancers, while 25 known DV enhancers were not identified
as significantly different between tissues. Closer inspection
revealed that the majority of known DV enhancers showed
some evidence for differential H3K27ac (see also Fig. 1b),
suggesting that the missed DV enhancers are not regulated
in a different manner but are largely due to noise in the
data and therefore did not pass our statistically stringent
criteria.
We then concentrated on putative distant enhancer
regions, which are at least 1 kb away from a transcription
(See figure on previous page.)
Fig. 1 Differential H3K27ac analysis across tissues is an effective method to identify tissue-specific enhancers. a Scatterplots of H3K27ac ChIP-seq
enrichment at each known DV enhancer (1 kb centered on midpoint) against the transcript levels of the known target gene show a good but
modest correlation in dorsal ectoderm precursor embryos gd7 (left) and in mesoderm precursor embryos Tl10b (right). ChIP-seq enrichment values
represent fold change over the corresponding input control after normalizing for differences in read count and fragment size. MEs mesoderm en-
hancers, DEEs dorsal ectoderm enhancers. b The correlation between H3K27ac and transcript levels becomes stronger when the fold changes in
H3K27ac levels between the two mutant embryos at each enhancer are plotted against the fold changes in transcript levels of the corresponding
target genes. See Additional file 3: Figure S1 for gene names. c De novo identification of DV enhancers based on CBP candidate regions and differential
H3K27ac analysis by the package DESeq2. Numerous candidate enhancers were located with CBP ChIP-seq data in wild-type embryos. DESeq2 was
then used to identify significant differences in H3K27ac between gd7 and Tl10b embryos within 1-kb windows centered on the CBP peaks. The
average DESeq2-normalized ChIP signal for all replicates is shown as a scatterplot on the right. CBP regions significantly different for H3K27ac
are shown in blue (MEs) and yellow (DEEs), while non-differential regions are shown in gray. d Average enrichment of H3K27ac in gd7 and Tl10b
embryos, as well as CBP in wild-type embryos, is shown for MEs and DEEs that were located distally, at least 1 kb from any transcription start site (TSS).
The gray bar represents the 1-kb window used to calculate H3K27ac enrichments, and the red box represents the 201-bp enhancer region. e
Examples of newly identified distal enhancers zfh1-ME2 and C15-DEE2. H3K27ac is shown as normalized ChIP enrichments over input, while
CBP is shown as normalized ChIP reads (reads per million). The gray bar represents the 1-kb H3K27ac window, and the blue and yellow boxes
represent the 201-bp ME or DEE enhancer region, respectively
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start site (TSS), since such distal enhancers have historic-
ally been more challenging to identify. Focusing on distal
enhancers also avoids confounding effects from differ-
ences in transcription as well as biases in sequence motifs
that are preferentially found in promoter regions. After ex-
cluding TSS regions, we obtained 416 putative MEs and
380 putative DEEs, summarized in Additional file 4: Table
S2. When we assigned these putative enhancers to the
nearest active gene based on mRNA-seq data, only 23 %
were assigned to a unique gene, while most assigned genes
had multiple putative enhancer regions (Additional file
3: Figure S6), consistent with previous findings [19, 44].
We named each putative enhancer based on the assigned
gene and enhancer type and numbered them based on the
location along the chromosome (e.g., C15-DEE1, C15-
DEE2, and so on). For completeness, we also assembled
and analyzed the list of putative enhancers that overlapped
a TSS (Additional file 5: Table S3), but we present here
our analysis on the distal enhancers.
As expected, the distal MEs and DEEs showed the
highest levels of H3K27ac in the flanking regions, on
average ~330 bp up- and downstream of the CBP peak
center (Fig. 1d). Analysis of individual regions confirmed
that H3K27ac peaks were typically enriched surrounding
the putative enhancers we identified (e.g., zfh1-ME2 and
C15-DEE2 in Fig. 1e).
Putative DV enhancers identified by differential
acetylation analysis show higher tissue specificity than
those identified by transcription factor occupancy
To validate the identified MEs and DEEs, we first analyzed
whether the mRNA-seq levels of the nearby genes were
significantly higher in the expected tissue (e.g., whether
the mRNA transcripts near MEs are significantly higher in
Tl10b over gd7). As a control group, we used the CBP
regions without differential H3K27ac (”non-differential
regions”, n = 6352). We found that 51 % of the closest ac-
tive genes are differentially expressed in the predicted tis-
sue, significantly higher than in the control group of CBP
regions, which have 31 % (p < 10−30, Fig. 2a). The second
nearest active genes were also slightly more differentially
expressed (p < 0.034) than the control, but the third near-
est genes were no longer enriched, consistent with en-
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Fig. 2 Genes near putative enhancers are differentially regulated across tissues. a The closest active genes near MEs and DEEs are significantly
differentially expressed in the expected tissue (Tl10b or gd7) as compared to non-differential control regions (p < 10−30, one-sided chi-squared test).
The second closest genes also show a small but significant enrichment (p < 0.034, one-sided chi-squared test), while the third nearest active genes
are no longer enriched over the control. b Fraction of genes with higher mesodermal expression (left) is largest among MEs, and that with higher
dorsal ectoderm expression (right) is largest among DEEs. As a comparison, the top 400 regions identified by transcription factor ChIP-seq data
are shown: Dl and Twi ChIP-seq experiments from Tl10b embryos, and Mad and Zen ChIP-seq experiments from gd7 embryos. The star marks
significance over non-differential regions (p < 0.01, one-sided chi-squared test). c Transgenic reporter activity of Vienna Tiles (VTs) that overlap
MEs, DEEs, and transcription factor ChIP regions are preferentially expressed during early embryonic stages (with annotated expression in any tissue at
stages 4–10). All groups show expression far above the average of all VTs (marked as star, p < 0.01, Fisher’s exact test). d VT reporter expression is more
tissue-specific for MEs and DEEs compared to transcription factor ChIP regions. ME reporter activity (left) was defined as annotations by Kvon et al. [39]
containing “mesoderm,” and DEE reporter activity (right) as annotations containing “amnioserosa.” The star marks significance over non-differential
regions (p < 0.01, Fisher’s exact test). Number of regions: all VTs (7705), early expressed VTs (1595), VTs overlapping putative DV enhancers
(148), MEs (68), DEEs (80)
Koenecke et al. Genome Biology  (2016) 17:196 Page 6 of 19
[39]. Overall, we found that a large fraction of putative DV
enhancers is associated with gene activation in the ex-
pected tissue.
To test whether our approach performs better than
previous methods, we performed the same analysis using
putative DV enhancers identified previously with ChIP-chip
experiments of Dl, Twi, and Sna in Tl10b embryos (high
confidence Dl Twi Sna (DTS) non-TSS regions, n = 213,
Zeitlinger et al. [19], obtained from http://younglab.wi.mi-
t.edu/dorsal/Dorsal_network_targets.txt). We also per-
formed ChIP-seq experiments of Dl and Twi in Tl10b
embryos as well as ChIP-seq experiments of Mad and
Zen in gd7 embryos. Although thousands of regions
were significantly bound in each ChIP-seq sample
(Additional file 6: Table S4), we selected the top 400 re-
gions based on highest confidence. In this manner, the
number of regions in the transcription factor groups
are similar to those identified by differential H3K27ac
and are likely of high quality, since known DV enhancers
tend to have higher occupancy of Dl, Twi, and Sna than
other regions [19].
We found that the fraction of regions for which the
nearest active gene showed differential expression was
higher for the MEs and DEEs identified by differential
H3K27ac than for the regions identified by transcription
factor occupancy in the corresponding tissue (Fig. 2b).
The result was particularly striking for DEEs, since re-
gions identified by Mad or Zen binding were only half as
likely as DEEs to have a nearby gene with higher expres-
sion in the dorsal ectoderm (Fig. 2b).
To more directly evaluate the ability of our MEs and
DEEs to drive reporter activity in the correct tissue, we
took advantage of the large-scale analysis of Vienna Tiles
(VTs) [39]. VTs are 2-kb non-coding genomic fragments
that have been analyzed for their ability to drive tran-
scription of a transgenic reporter during Drosophila em-
bryogenesis. There are 148 of these VTs that overlap
with our identified MEs and DEEs.
We first calculated the fraction of these VTs that drive
reporter activity in any tissue during early embryogen-
esis. We found that among VTs that overlap MEs, DEEs,
or the 400 top regions for each transcription factor, at
least 65 % had early reporter gene activity in each group
(Fig. 2c), significantly above the 20 % average of all VTs
(Fig. 2c). This suggests that differential acetylation and
transcription factor occupancy are both successful in
identifying bona fide enhancers.
There was, however, a noticeable difference in the de-
gree of tissue specificity between the groups (Fig. 2d).
Among the 68 VTs overlapping our identified MEs, 53 %
have mesodermal tissue expression annotations, as de-
termined by Kvon et al. [39]. In comparison, only 10 %
of non-differential control regions had such annotations
(Fig. 2d, p < 10−24). Among ChIP regions, those identified
with mesodermal transcription factors (DTS, Dl, and Twi)
also drove reporter activity in the mesoderm more often
than the non-differential control regions, but the percent-
ages were not as high as for the newly identified MEEs
(32 %, 24 %, and 42 %, respectively, Fig. 2d).
Similarly, 33 % of VTs that overlap our identified DEEs
have annotated expression in the amnioserosa (a dorsal
tissue that can easily be queried). In comparison, 5 % of
VTs of non-differential control regions show this anno-
tation (p < 10−19). The ChIP-based regions identified
through transcription factors active in the dorsal ecto-
derm (Mad and Zen) also performed significantly above
the control (24 % and 21 %, respectively) but not as
highly as the DEEs (33 %) (Fig. 2d).
This suggests that transcription factor ChIP regions
are highly enriched for enhancers, but that even highly
bound regions may not be active in the tissue analyzed.
Overall, differential H3K27ac analysis is very reliable in
identifying enhancers with differential activity in the ex-
amined tissues.
Putative DV enhancers are enriched for expected
transcription factor motifs
Our putative MEs and DEEs were not based on prior
knowledge of the DV transcriptional network, and thus
we used this opportunity to ask whether we could redis-
cover the known cis-regulatory motifs among these se-
quences. To perform a comprehensive motif analysis, we
collected all known Drosophila transcription factor motifs
from FlyFactorSurvey [45] and JASPAR [46] and used
FIMO [47] to score their presence in all ME and DEE se-
quences (201 bp centered at the CBP peak).
We then scored the relative motif enrichments among
MEs or DEEs over non-differential H3K27ac control re-
gions, or DEEs over MEs using a Fisher exact test (p < 0.05
after Benjamini-Hochberg correction, Fig. 3a). To avoid
false positives, we only scored motifs for which the tran-
scription factor was expressed in either the mesoderm
(Tl10b) or dorsal ectoderm tissue (gd7). We then collapsed
motifs whose occurrences substantially overlapped (see
Methods). In these cases, we show the most significant
motif with the corresponding transcription factor, as well
as other transcription factors if they have known roles in
DV patterning. In total, we found 13 independent motifs
that were significantly enriched in our putative DV en-
hancers (Fig. 3a).
Our unbiased motif discovery captured motifs for all
well-established DV transcription factors. Among MEs,
motifs for Dl and Twi were enriched, as expected, as
well as the motif for Tinman (Tin), a transcription fac-
tor that is known for its role in muscle development
[18, 48, 49].
Among DEEs, we found the motifs for Zen, Zld, and
Brinker (Brk), as expected. The Brk motif is bound by
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Fig. 3 (See legend on next page.)
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Mad, the downstream nuclear target of the Dpp signal-
ing pathway, in competition with Brk [50–53]. The Zen
motif was similar to other homeodomain motifs, includ-
ing that of Even-skipped (Eve), which scored even higher
than that of Zen.
Among DEEs, we also identified the Sna motif as
highly enriched. Since Sna is expressed in the mesoderm,
this suggests that Sna represses dorsal ectodermal genes.
Indeed, while Sna is better known for repressing neurec-
todermal genes [5], Sna has also been shown to repress
the dorsal ectodermal gene pannier (pnr) [54]. Further-
more, highly conserved Sna motifs have previously been
found in putative dorsal ectodermal enhancers [19].
To test whether our identified motifs are indeed bound
by the expected DV transcription factors in vivo, we ana-
lyzed the motifs’ enrichments in the respective ChIP-seq
data from Dl, Twi, Sna, Zen, Mad, and Zld. We found that
MEs and DEEs with the motifs showed enriched ChIP oc-
cupancy of the corresponding transcription factor com-
pared to MEs and DEEs without the motif (Additional file
3: Figure S7). It remains to be shown whether other tran-
scription factors known to bind similar motifs in vitro also
bind to these motifs in vivo, perhaps in competition with
the known DV transcription factors.
Among the remaining motifs, a large fraction of asso-
ciated transcription factors are themselves expressed in a
DV-biased fashion (ribbon (rib), knirps (kni) on the ventral
side, Distal-less (Dll), tail-up (tup), jim lovell (lov, also
known as CG16778) on the dorsal side, Fig. 3b), and some
of them have known roles in early development. rib is
expressed mostly at the poles and in some ventral cells
and encodes a Bric-a-brac, Tramtrack, Broad (BTB) do-
main transcription factor with known roles in morphogen-
esis [55]. kni is expressed at the most anterior ventral cells
and plays a role during head development [56], in addition
to its well-known role as gap gene. The enhancer that
mediates the anterior ventral expression pattern of kni
[19, 57] was among our putative MEs (kni-ME5), con-
firming that kni is part of the DV network.
On the dorsal side, the zen expression pattern (stage 5)
is similar to that of tup, a known target of Dpp [19, 58]
that encodes another homeodomain transcription fac-
tor essential for amnioserosa development [59]. A third
homeodomain transcription factor, Dll, is expressed in
a subset of two narrow stripes on the dorsal side, in
areas where zen and tup appear to be low (Fig. 3b).
A motif most similar to the Dll motif has previously
been shown to be essential for the expression of a
dorsal ectodermal enhancer (TTAATTGC in the pnr
enhancer [54]), consistent with Dll being part of the
DV network. Finally, lov is specifically expressed on
the dorsal side of the embryo (Fig. 3b) [60]. It encodes a
BTB domain transcription factor that recognizes a
motif very similar to that of Twi in vitro [45]. It is
therefore conceivable that it represses Twi targets on
the dorsal side.
While most of the transcription factors that we identi-
fied in our motif analysis are already known targets of
the DV network, Rib, Dll and Lov are not. If these genes
are in fact involved in DV patterning, we would expect
them to have DV-regulated enhancers themselves. In-
deed, among our MEs and DEEs, we found putative en-
hancers for lov and Dll that had the characteristics of
typical DV enhancers (Fig. 3c). In each case, the DEE
overlapped with a VT that drove expression in the ap-
propriate DV pattern and showed high occupancy of
Mad and Zen. We therefore added Lov and Dll to the
known DV network (Fig. 3d).
As a control, we also performed the same motif ana-
lysis on the putative enhancer regions identified by
transcription factor occupancy. While we identified a
large number of enriched motifs, the motifs were sur-
prisingly different between all transcription factors and
were hard to interpret, especially with regard to tissue
specificity (Additional file 3: Figure S2). This further
corroborates our conclusion that transcription factor
occupancy is not ideal for identifying tissue-specific
enhancers.
(See figure on previous page.)
Fig. 3 The identified putative DV enhancer regions are enriched for known DV transcription factor motifs. a Known Drosophila motifs that are
significantly enriched (red) or depleted (blue) at MEs or DEEs over non-differential control regions, or DEEs over MEs, are shown as sequence logos
in bits on the left. The transcription factor that is known to bind the motif is shown on the right. If there are several transcription factors (TFs), all
matches are shown, and the factor that is known to function during DV patterning is underlined. Significance was determined by a one-sided
proportion test (* p < 0.05, ** p < 10−2, *** p < 10−3, **** p < 10−4, ***** p < 10−5 after Benjamini-Hochberg correction). b Many identified transcription
factors are expressed in a DV-specific pattern themselves, e.g., localized to the mesoderm (top) or the dorsal ectoderm (bottom) in in situ hybridization
images from stage 4, obtained from the Berkeley Drosophila Genome Project (BDGP) in situ hybridization database [73–75]. Among them are lov and
Dll, which are expressed in the dorsal ectoderm. c Expression of lov and Dll in the dorsal ectoderm could be mediated by two enhancers identified
among DEEs (lov-DEE4 and Dll-DEE-TSS). Overlapping VTs drive reporter activity similar to the endogenous genes. Both enhancers are occupied by
Mad, Zen, and Zld based on ChIP-seq data, indicating direct regulation by the DV network. Dl, Twi ChIP-seq are from Tl10b embryos, Sna ChIP-seq from
wild-type embryos, and Mad, Zen, Zld ChIP-seq from gd7 embryos. d DV regulatory network based on the rediscovered transcription factors and lov
and Dll as added components (boxed). The shown regulatory interactions are based on literature knowledge, confirmed by our own ChIP-seq data.
Shown in red are transcription factors that likely function as repressors, since the tissue in which they are expressed is distinct from the tissue of their
target genes
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Phylogenetic conservation of motifs among putative DV
enhancers
Phylogenetic sequence conservation (“phylogenetic foot-
printing”) of regulatory regions, and specifically of the
transcription factor binding motifs within them, has long
been used to identify functional enhancers and motifs
[61, 62]. When we analyzed the newly identified enhancers,
we noticed that the identified transcription factor motifs
were often found within sequence blocks of high conserva-
tion across the Drosophila phylogeny, interspersed by more
diverged sequences within the same enhancer region. For
example, a canonical Twi binding motif in the newly identi-
fied if-ME3 enhancer is in a highly conserved sequence
block, while a partially conserved sequence block right next
to it contains two Dl binding motifs (Fig. 4a left). Likewise,
a putative DEE, Btk29A-DEE1, has two conserved, presum-
ably repressive, Sna binding motifs next to a conserved ca-
nonical Zen binding motif, each in a conserved sequence
block (Fig. 4a right).
We therefore tested more systematically whether the
identified motifs tended to be among blocks of conserva-
tion (Fig. 4b). As a baseline control, we first calculated
the average phastCons score of all MEs and DEEs and
found it to be significantly above that of random non-
TSS regions (Fig. 4b, 56 % ”MEs + DEEs” versus 43 %
”Random non-TSS,” p < 10−43), showing that ME and
DEE 201-bp sequences are evolutionarily conserved
above average. We then calculated the average phast-
Cons score for each identified DV motif among all MEs
or DEEs (Fig. 4b ”Motifs only”) and compared it to the
average phastCons score for all MEs and DEEs where
the motifs were found (Fig. 4b ”MEs +DEEs with motif”).
This allowed a direct comparison between the conserva-
tion of the motif and that of its surrounding regions.
This analysis shows that the motifs found in putative
DV enhancers (”Motifs only”) for Tin, Rib, Zld, Sna, Eve,
Dll, BEAF-32, HLH106, Abd-B, and Brk are significantly
more conserved than their surrounding regions ”MEs +
DEEs with motif” (Fig. 4b), which are already conserved
above average. The highest conservation was found for
the homeodomain motifs (Eve, Dll, Abd-B) and the Brk
motif (Fig. 4b), which suggests a prominent and ancient
role of homeodomain transcription factors in the devel-
opment of dorsal ectoderm. Taken together, these results
further validate our method to identify enhancers based
on differential acetylation.
Novel DV target genes involved in morphogenesis
Our list of newly identified MEs and DEEs is highly
enriched for bona fide DV target enhancers based on
independent assays such as mRNA expression and
transgenic reporters. Yet, these putative DV enhancers
may contain false positives, and thus we focused on
high-confidence DV enhancers and their potential target
genes to gain a better understanding of all the genes that
are targeted by the DV network.
First, we assembled all putative DV enhancers that
have high ChIP-seq occupancy of DV transcription fac-
tors (Dl, Twi, Mad, or Zen) and have a nearby gene that
is upregulated in the expected tissue based on mRNA-
seq data. We then grouped the enhancers based on their
pattern of DV transcription factor occupancy and the
tissue in which they are active (Fig. 5a). Second, we as-
sembled novel DV enhancers that overlapped a VT
whose expression pattern matched that of the assigned
nearby gene (Fig. 5b).
Among these high-confidence DV enhancers, a large
fraction of the target genes encode transcription factors
and signal transduction molecules, many of which were
previously known or have fitting roles in DV patterning
(e.g., cv-2, Dtg, tok in the Dpp signaling pathway). How-
ever, we also identified a number of genes that likely play
a role in the morphogenesis of the developing tissues,
including genes regulating the cytoskeleton or cell adhe-
sion (Fig. 5a). Many of these novel putative morphogen-
esis genes have high Dl occupancy (be, GEFmeso, if, lbk,
scra, Zasp52), suggesting that they are directly activated
by Dl on the ventral side and thus could play a role in
initiating the gastrulation movements. Interestingly, mew
is among the putative morphogenesis genes that is re-
pressed by Dl and expressed on the dorsal side. mew and
if are both alpha integrins but with different specificities
in the extracellular domain [63], suggesting that their
early differential DV expression may confer the develop-
ing tissues’ different cellular properties. Taken together,
the identified DV enhancers provide novel target genes
of the DV network, including genes that may mediate
the differential cellular behavior of the analyzed tissues.
Discussion
We showed that large-scale selection of candidate re-
gions in combination with differential H3K27ac analysis
between tissues is a simple and very effective technique
for the identification of tissue-specific enhancers. Our
approach did not require knowledge of relevant tran-
scription factors and even performed better than ChIP-
seq data of such factors. While regions identified by
transcription factor occupancy were equally enriched for
enhancers, they were more likely to drive expression in
neighboring tissues than those identified through differ-
ential acetylation analysis. This was not due to technical
limitations, since the ChIP-seq data are of high quality
and the transcription factors are genetically required for
DV patterning.
We argue that histone acetylation more accurately re-
flects an enhancer’s activity than the binding of transcrip-
tion factors. This happens because high transcription factor
occupancy is sometimes found at enhancers that are not
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Fig. 4 (See legend on next page.)
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active, presumably due to repression [18, 19]. Furthermore,
histone acetylation can be measured in all tissues and thus
allows the detection of relative differences between tissues,
while transcription factor binding can only be measured in
the tissue in which the transcription factor is expressed.
Analyzing relative differences in H3K27ac between tis-
sues provides several benefits over analyzing each tissue
separately. First, differential enhancer activity is likely
more biologically relevant than the analysis of individual
tissues. Traditionally, differential gene expression (e.g.,
visualized by mRNA in situ hybridization), rather than
absolute gene expression levels, has been regarded as a
hallmark of tissue patterning during development. Second,
differential H3K27ac analysis specifically identifies en-
hancers that are different between tissues and disregards
enhancers that are equally active in both tissues. In our
system, this enabled us to specifically identify enhancers
that are part of the Dl patterning network, including
downstream transcription factors, signaling pathways, and
morphogenesis genes. Third, differential H3K27ac analysis
allows, in principle, the identification of enhancers that are
active in only a subset of a tissue (e.g., kni and Dll). In this
case, the relative difference between tissues is smaller but
can still be detected if within the sensitivity of the assay.
While differential acetylation analysis has clear advan-
tages, it also has limitations. Since histone acetylation is
broadly distributed and most highly detected next to the
actual enhancer regions where the transcription factors
are bound, methods that rely on histone acetylation alone
for enhancer detection are inherently limited in resolution.
In our approach, we alleviate this problem by independ-
ently gathering information on the likely position of en-
hancer regions (through CBP or ATAC-seq). However,
enhancers are often in close proximity to each other;
therefore, we cannot exclude the possibility that some of
the identified regions show differential acetylation due to
their proximity to bona fide enhancers (spill-over effect).
Indeed, we often identified multiple putative enhancers
next to each other. These closely spaced putative en-
hancers could all be functional, since it is common for
multiple enhancers to regulate a single gene’s expression
pattern together [19, 44]. However, they may also include
false positives due to the spill-over effect. Our validation
assays, testing for proximity of putative enhancers to regu-
lated genes and the 2 kb-long transgenic reporters, did not
provide sufficient resolution to probe this potential source
of false positives. A large fraction of false positives is
unlikely though, since the identified regions were sig-
nificantly enriched for the expected transcription factor
motifs.
While the number of false positives in our DV enhan-
cer list is unknown, there were false negatives, since our
list did not include many of the known DV enhancers.
We found that several known enhancers missed the cut-
off for significance, not due to lack of differences in
H3K27ac but due to noise. This suggests that future im-
provements in technology, such as tighter selection for
embryos of the right stage and improved sequence
coverage, have the potential to further improve the ac-
curacy of our method. It will also be interesting to test
whether adding data on the acetylation of other histone
residues, such as H3K9ac or H3K16ac, H3K122ac, or
H3K56ac [64], improves the results.
The advantage of differential acetylation analysis in
combination with candidate region detection is that it
does not require prior knowledge of the specific tran-
scription factors involved in each tissue. Since histone
modifications are well conserved across species and their
antibody specificities are well characterized, this method
should be broadly applicable to many uncharacterized
developmental systems. The numbers of cells required
as starting material for ChIP-seq are also lower for his-
tone modifications than for transcription factors (and
are even lower for ATAC-seq [32]). While the material
requirements might still exceed what can be obtained
from mammalian embryonic tissues, our method could
be applied to mammalian in vitro differentiation systems,
e.g., to detect differential enhancer activity in response to
extracellular signals.
Conclusions
Differential acetylation analysis provides an excellent
starting point for identifying enhancers and their tran-
scription factor binding motifs in an uncharacterized
(See figure on previous page.)
Fig. 4 Transcription factor binding motifs are conserved in novel DV enhancers. a Examples of conserved motif instances within a mesoderm
enhancer (if-ME3, left), close to the gene inflated (if ), and a dorsal ectoderm enhancer (Btk29A-DEE1, right), close to the Btk29A gene. H3K27ac is
shown as normalized ChIP enrichment over input in Tl10b and gd7 embryos. ChIP-seq occupancy is shown for Twi and Dl (left) and Zen and Sna
(right) as ChIP-seq reads normalized to reads per million. A close-up of the if-ME3 sequence shows a canonical Twi binding motif (E-box) and two Dl
binding sites that are conserved across several Drosophila species. A close-up of the Btk29A-DEE1 sequence shows two canonical Sna binding
motifs and a canonical Zen binding motif that reside in islands of conservation. Conservation data are phastCons data obtained from the
UCSC genome browser [72]. b Conservation of all identified DV motifs among all MEs and DEES. The average phastCons score for all putative
DV enhancers (”MEs + DEEs” in dark gray) is significantly higher compared to control regions (”Random non-TSS” in light gray). The average
phastCons score of each DV motif (”Motifs only” in red) is in many cases higher than that of the surrounding regions (”MEs + DEEs with motif”
in light red). This confirms that motifs like that of Zen and Sna are indeed preferentially found in islands of conservation. Significance was
determined by Wilcoxon rank-sum test and marked with a star (p < 0.05)
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Fig. 5 (See legend on next page.)
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developmental regulatory network. The challenge in the
future will be to make the generation of such data tech-
nically possible with relatively low amounts of starting
material, e.g., when working with mammalian embryos.
Undoubtedly, future improvements and innovations in
genomics technology will greatly facilitate this goal.
Methods
Stock maintenance and embryo collection
The fly stock Tl10b is from Indiana University (30914,
Bloomington Stock Center, Bloomington, IN). The gd7
and Tlrm9/rm10 stocks were kind gifts from Mike Levine
(Princeton University). For Tl10b embryo collections,
T(1;3)OR60/Tl10b, e1 females and Tl10b/TM3, e1, Sb1,
Ser1 males were selected from the stock consisting of ge-
notypes Tl10b/TM3, e1, Sb1, Ser1 and T(1;3)OR60/TM3,
e1, Sb1, Ser1. The gd7/gd7 females and gd7/Y males were
used for embryo collections and were obtained from the
gd7/winscy, hs-hid stock by heat shocking 1-day-old lar-
vae for 1 h at 37 °C, followed by a second heat shock
24 h later. Tlrm9/rm10 females and males were selected
for embryo collections from offspring originating from
the crossing of virgin females from the stock Tlrm9/TM3,
e1, Sb1, Ser1 with males from the stock Tlrm10/TM3, e1,
Sb1, Ser1. Oregon R embryos were used for wild-type
samples.
All genotypes were expanded into population cages,
and embryos were collected 2–4 h after egg deposition
(AED). Apple juice plates were placed into the popula-
tion cage at 25 °C for 2 h and then outside at 25 °C for
another 2 h. For ChIP-seq experiments, embryos were
dechorionated for 1 min with 100 % bleach and then
cross-linked for 15 min with 1.8 % formaldehyde (final
concentration in water phase). For mRNA-seq and
ATAC-seq experiments, embryos were dechorionated
but not cross-linked.
ChIP-seq experiments
ChIP-seq experiments were performed as described
[21, 23] with the following differences: ~100 mg em-
bryos were used per ChIP and more extensive RIPA
buffer washes were performed after H3K27ac ChIP
incubation to reduce background. The antibodies used
for ChIP-seq were custom-generated by GenScript: Dl
(aa 39–346), Mad (aa 148–455), Zen (full length), Sna
(full length), CBP (aa 2528–2872), and Zld (aa 1117–
1327). Antibodies for Twi (aa 340–490) were custom-
generated by Covance and antibodies for H3K27ac
were obtained from Active motif, 39133. Tl10b embryos
were used for ChIP-seq for Dl and Twi, and H3K27ac,
wild-type embryos for CBP and Sna, and gd7 embryos
for Mad, Zen, Zld, and H3K27ac.
Library preparation
Different combinations of library preparation kits and
barcodes were used for library preparations (see Additional
file 6: Table S4), and libraries were prepared according to
manufacturer instructions. ChIP-seq libraries were pre-
pared from 5–15 ng ChIP DNA or 100 ng input DNA and
sequenced on the GAIIX (Illumina) or the HiSeq 2500
(Illumina).
ChIP-seq data processing
All ChIP-seq samples were aligned to the Drosophila
melanogaster UCSC dm3 reference genome using
Bowtie v1.1.1 [65] with a maximum of two mis-
matches. Only uniquely aligning reads were used. The
Bioconductor package chipseq was used to extend
each sample’s aligned reads to the estimated fragment
size. All ChIP-seq enrichment values were calculated
as fold change over the corresponding input sample,
after normalizing for differences in read count and
fragment size. CBP peaks were first called with peak-
zilla [66] using default parameters for the CBP wild-
type ChIP-seq and its corresponding input control.
Detected peaks were resized to 201 bp centered at
the summit, and those with less than twofold enrich-
ment were excluded. To assess sample quality,
MACS2 was run on all samples with their corre-
sponding tissue’s input control and these non-default
parameters:
macs2 callpeak -t ip.bam -c wce.bam -g dm --keep-dup
= all
(See figure on previous page.)
Fig. 5 High-confidence DV enhancers identify novel DV target genes. a All MEs and DEEs that were confirmed by high occupancy of DV
transcription factors and differential target gene expression by mRNA-seq. The occupancy of DV transcription factors Dl, Twi, Sna, Zen, Mad, and
Zld is shown as a heatmap of normalized ChIP enrichment over input. The enhancers were categorized based on the function of their target
genes (transcription factors, signaling, morphogenesis, other) and whether they have high occupancy of Dl, Mad (green and light brown bars,
respectively), which indicates that they are likely direct targets of the signaling cascade. b A selection of MEs and DEEs that were confirmed by in
vivo reporter expression of overlapping Vienna Tiles (VTs), which match the expression pattern of the assigned target gene. In situ hybridization
images for VTs were obtained from Kvon et al. [39]. Unless noted otherwise, the in situ hybridization images for target genes are from the BDGP
database [73–75]. The CadN expression pattern is by Biemar et al. [17], copyright (2006) National Academy of Sciences, USA; that of be is from
Fly-FISH [76, 77] and was color-modified to resemble the black-and-white in situ hybridization images, reused with permission; that of Wnt2 is
from Russell et al. [78] Copyright 1992 The Company of Biologists, and that of Stat92E is from Yan et al. [79], reprinted from Yan et al., Identifica-
tion of a Stat gene that functions in Drosophila development. Cell, 84(3):421–430, Copyright 1996, with permission from Elsevier
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Peak counts for each sample can be found in Additional
file 6: Table S4.
mRNA-seq experiments
Total mRNA was extracted from 20–100 mg Tl10b em-
bryos in duplicates and from gd7 and Tlrm9/rm10 embryos
in triplicates using the Maxwell Total mRNA purifica-
tion kit (AS1225, Promega) according to the manufac-
turer’s instructions. PolyA-mRNA was isolated using
Dynabeads oligo (dT) (61002, Life Technologies). Libraries
were prepared following the instructions of the TruSeq
DNA Sample Preparation Kit (FC-121-2001, Illumina) and
sequenced on the HiSeq 2500 (Illumina).
mRNA-seq data processing
The mRNA-seq replicates from Tlrm9/rm10, Tl10b, and gd7
were aligned with TopHat v2.0.14 [67] to the FlyBase
r5.57 reference genome and gene annotations with the
following non-default parameters:
tophat -G fb557_genes.gtf -I 20 -I 5000 --no-coverage-
search --segment-length 25
Cuffdiff, from Cufflinks v2.2.1 [68], was used to deter-
mine transcript abundance and differential expression
between all three pairwise combinations of DV mutants.
ATAC-seq experiments
ATAC-seq was performed in biological duplicates using
20 mg 2–4 h AED Oregon R embryos. Nuclei were iso-
lated by douncing the embryos in HBS buffer (0.125 M
sucrose, 15 mM Tris (pH 7.5), 15 mM NaCl, 40 mM
KCl, 2 mM EDTA, 0.5 mM EGTA) in a 2-ml dounce tis-
sue grinder followed by filtering the nuclei suspension
through Miracloth (475855, Calbiochem). Nuclei were
spun at 500 g for 5 min at 4 °C, and the supernatant was
discarded. ATAC-seq was performed as described [32]
using 2.5 μl Tn5 transposase and PCR reagents from the
Nextera DNA Sample Preparation Kit (FC-121-1030,
Illumina). In addition, the Nextera index kit (FC-121-
1011, Illumina) was used to create libraries. Libraries
were purified using Agencourt AMPure XP beads
(A63881, Beckman Coulter), and paired-end sequencing
was performed on the NextSeq (Illumina).
ATAC-seq data processing
ATAC-seq paired-end reads were trimmed to 25 base
pairs and aligned in paired-end mode with Bowtie v1.1.1,
keeping only unique alignments with a maximum of two
mismatches per read and an insert size of less than or
equal to 1000 bp. MACS2 v2.1.0.20150420 [69] was used
to identify ATAC peaks after combining both replicates
using the following parameters:
macs2 callpeak -t orer_combined_atac.bam -g dm -n
orer_combined_atac -f BAMPE --call-summits
Identification of differential H3K27ac regions
The Bioconductor package DESeq2 v1.10.1 [43] was used
to identify peaks with differential H3K27ac read counts be-
tween the two or three replicates using default parameters
and an adjusted p value cutoff of 0.01. For this, the reads
overlapping a 1-kb window centered on the summit of
either 201-bp CBP or ATAC reads were counted in two
replicates in gd7 and three replicates in Tl10b. Regions were
classified into TSS (less than 1000 bp from a FlyBase 5.57
annotated TSS), intragenic (inside an annotated gene but at
least 1000 bp from a TSS), and intergenic (outside an anno-
tated gene but at least 1000 bp from a TSS) enhancers.
The average DESeq2 normalized ChIP signal for all repli-
cates is shown in Fig. 1c and Additional file 3: Figure S3a.
Metapeak profiles of putative DV enhancers
The average enrichment of Tl10b H3K27ac, gd7 H3K27ac,
and wild-type CBP ChIP-seq profiles over their respective
input controls was calculated for putative MEs and DEEs
after normalizing for differences in read count and frag-
ment size. Enrichment values at each base relative to the
CBP summit were smoothed with a 31-bp sliding window
for display. ATAC-seq metapeak profiles display ATAC-
seq average reads per million without any smoothing.
Calculation of transcription factor enrichments
Transcription factor enrichments within our 201-bp pu-
tative enhancers were calculated by finding the summit
within each enhancer for each transcription factor ChIP-
seq sample and calculating the read count and fragment
length-normalized enrichment over input in a 201-bp
window around the summit.
Nearest gene analysis
To assign regions (such as putative enhancers, non-
differential regions, and transcription factor peaks) to
the nearest gene, only genes with an mRNA-seq frag-
ments per kilobase of exon per million fragments
mapped (FPKM) of at least 5 in either gd7or Tl10b were
considered. Regions overlapping an expressed gene were
assigned to that gene; otherwise, the gene with the clos-
est TSS was assigned. For transcription factors, we se-
lected the top 400 peaks by peakzilla score from the
replicate with the most number of detected peaks.
Known motif enrichment analysis
Drosophila melanogaster motifs in the Bioconductor
MotifDb package v1.10 [70] were first filtered to include
only those where the corresponding transcription factor
is expressed in either gd7 or Tl10b (mRNA-seq FPKM
greater than 3). Motifs derived from daughterless (da)
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heterodimers in the FlyFactorSurvey database [45] were
also excluded. The genomic locations of all remaining
motifs were obtained using FIMO [47], part of the
MEME Suite v4.10.1 [47], with the following parameters:
fimo --text --bgfile dm3_background.markov
motif.meme dm3.fasta
The background frequency file was obtained using the
MEME tool fasta-get-markov against the modENCODE
cold/warm/hot transcription factor binding regions
(Dataset S8 from Roy et al. [71]).
Using a test and control group of regions, each region is
scored for the presence or absence of every motif. The
counts of regions containing the motif in the test group are
compared to the counts of regions containing the motif in
the control group using a one-sided proportion test.
Resulting p values are corrected for multiple testing using
the Benjamini-Hochberg method. As shown in Fig. 3a, pu-
tative MEs, DEEs, and non-differential regions were all
201 bp in width (centered at the CBP binding summit).
Additional file 3: Supplementary figures: Figure S2
shows the top 500 non-TSS peaks for each factor com-
pared to all remaining non-TSS peaks. All regions were
resized to 201 bp centered at the peak summit.
To combine similar motifs, the percentage of overlap
among all occurrences was calculated between all pairs
of significantly enriched motifs within either the putative
enhancers (Fig. 3a) or all non-TSS peaks among the dis-
played factors (Additional file 3: Figure S2 and Figure
S5). Motifs that overlapped each other in more than
10 % of occurrences were grouped as similar, and the
motif with the lowest p value in the enrichment test
was displayed as representative of the group.
Motif conservation analysis
Per-base phastCons scores for the Drosophila melanoga-
ster dm3 genome were downloaded from the UCSC
Genome Browser (http://hgdownload.soe.ucsc.edu/gold-
enPath/dm3/database/phastCons15way) [72]. For each
motif, the average phastCons score of all motif instances
within each 201-bp putative DV enhancer was paired
with the average phastCons score of the entire enhancer
region. Significance was determined using a Wilcoxon
paired rank-sum test. In addition, the average phastCons
scores of all putative DV enhancers were compared to
5000 random non-TSS regions of equal width using a
Wilcoxon unpaired rank-sum test.
Transcription factor binding and motif presence analysis
As shown in Additional file 3: Figure S7, a two-sided
Wilcoxon test is used to compare the ChIP-seq enrich-
ment values of each transcription factor at putative DV
enhancers containing each motif to those enhancers
lacking the motif.
Vienna Tiles analysis
As shown in Fig. 2d, annotated Vienna Tiles (VTs) over-
lapped by each region group (putative DV enhancers
and the top 400 non-TSS peaks from Dl, Twi, Mad, and
Zen ChIP-seq) were identified. The proportions of over-
lapping VTs in each group with annotated expression
terms containing “mesoderm” and “amnioserosa” were
determined and compared to all VTs overlapping non-
differential CBP peaks using a one-sided proportion test.
A similar analysis was performed (see Fig. 2c) using
the proportion of VTs with expression in stages 4–6, 7–8,
or 9–10 compared to all annotated VTs.
Transcription factor binding at selected putative DV
enhancers
As shown in Fig. 5a, putative DV enhancers were se-
lected based on the expression of the nearest gene and
transcription factor binding. First, putative DV en-
hancers overlapping known enhancers were removed.
Next, putative DV enhancers where the nearest gene’s
mRNA-seq expression was highest in Tlrm9/rm10 com-
pared to both Tl10b and gd7 were also removed in order
to exclude neuroectodermal genes. Finally, putative DV
enhancers where the tissue of differential H3K27ac did
not match the tissue of differential expression of the
nearest gene were removed. For the remaining putative
MEs, those with Dl ChIP-seq enrichment of at least
threefold over input were assigned to the “Dl binding”
group. Those with Twi ChIP-seq enrichment of at least
fivefold but Dl ChIP-seq enrichment less than threefold
were assigned to the “Twi” group. For the remaining pu-
tative DEEs, those with a Mad ChIP-seq enrichment of
at least threefold were assigned to the “Mad binding”
group, and those with a Zen ChIP-seq enrichment of at
least threefold but a Mad ChIP-seq enrichment less than
threefold were assigned to the “Zen binding” group. All
other putative enhancers not assigned to one of the four
transcription factor groups are not displayed. Enrichment
values displayed in the heatmap were independently nor-
malized for each factor to be between 0 (no enrichment
over input or less) and 1 (98th percentile enrichment or
higher).
Additional files
Additional file 1: Supplementary material: Includes references for
known DV enhancers, ChIP-seq and ATAC-seq replicate correlations, and
an overview of how some known DV enhancers were assigned to potential
target genes. (DOCX 3548 kb)
Additional file 2: Table S1. Spreadsheet showing known DV enhancers
assembled from the literature that were used in this study. (XLSX 14 kb)
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Additional file 3: Supplementary figures: Fig. S1: Gene names for the
data shown in Fig. 1a–c, Fig. S2: Transcription factor motifs enriched in
top ChIP-seq and ATAC-seq regions, Fig. S3: Differential H3K27ac analysis
of ATAC-seq regions is an effective method to identify tissue-specific
enhancers, Fig. S4: Genes near putative ATAC-seq derived enhancers are
differentially regulated across tissues, Fig. S5: The identified putative DV
enhancer regions derived from ATAC-seq are enriched for known DV
transcription factor motifs, Fig. S6: Number of genes with one or multiple
assigned enhancers, Fig. S7: Transcription factor ChIP-seq signal is prefer-
entially found at the expected corresponding binding motifs present within
putative MEs and DEEs. (PDF 2673 kb)
Additional file 4: Table S2. Spreadsheet of all distal identified DV
enhancers, the assigned gene and its expression in the DV mutants,
H3K27ac and transcription factor ChIP enrichment, overlap with known DV
enhancers and Vienna Tiles, enrichment for transcription factor motifs, and
classification as high confidence enhancers (used in Fig.5). (XLSX 256 kb)
Additional file 5: Table S3. Spreadsheet showing all identified DV
enhancers that overlap a gene’s TSS, the assigned gene and its
expression in the DV mutants, H3K27ac and transcription factor ChIP
enrichment, and overlap with known DV enhancers and Vienna Tiles.
(XLSX 147 kb)
Additional file 6: Table S4. Spreadsheet detailing the samples used in
this study and the library preparation kits the libraries were created with,
number of total reads, aligned reads, and MACS peaks for each sample.
(XLSX 11 kb)
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